Literature DB >> 27129500

Frameshift Mutations of HSPA4 and MED13 in Gastric and Colorectal Cancers.

Yun Sol Jo1, Mi Ryoung Choi1, Sang Yong Song2, Min Sung Kim1, Nam Jin Yoo1, Sug Hyung Lee3.   

Abstract

Frameshift mutation of genes containing mononucleotide repeats is a feature of gastric (GC) and colorectal cancers (CRC) with microsatellite instability (MSI). In the public genome database, we found that human HSPA4 gene encoding a heats hock protein 70 protein (HSP70-4) and MED13 gene had mononucleotide repeats in the coding sequences that could be targets for frameshift mutation in cancers with MSI. HSP70-4 is a member of HSP70 that is known to play a role in cell survival. MED13 is a member of MED genome-wide transcription regulators that function as a regulator for diverse biological processes. In this study, we analyzed the mutations in 79 GCs and 124 CRCs including high MSI (MSI-H) and microsatellite stable/low MSI (MSS/MSI-L) cases by single-strand conformation polymorphism analysis and DNA sequencing. We found frameshift mutations of HSPA4 gene in two cancers (one GC and one CRC) and MED13 gene in the other two cancers (one GC and one CRC). The frameshift mutations were deletions of one base (c.2396delA (p.Asn799MetfsX50)) in HSPA4 and (c.2175delA (p.Lys725AsnfsX4)) in MED13. Each of HSPA4 and MED13 mutations were detected in GC with MSI-H (1/34: 2.9 %) and CRC with MSI-H (1/79: 1.3 %), but not in those with MSS. Our data show that unconventional HSPA4 and MED13 genes harbored frameshift mutations in GC and CRC with MSI. These mutations might possibly inactivate their functions and could be a feature of GC and CRC with MSI-H.

Entities:  

Keywords:  Cancers; HSP70; HSPA4; MED13; Microsatellite instability; Mutation

Mesh:

Substances:

Year:  2016        PMID: 27129500     DOI: 10.1007/s12253-016-0070-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  14 in total

1.  Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.

Authors:  Eun Mi Je; Mee Ran Kim; Ki Ouk Min; Nam Jin Yoo; Sug Hyung Lee
Journal:  Int J Cancer       Date:  2012-05-08       Impact factor: 7.396

2.  MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.

Authors:  Netta Mäkinen; Miika Mehine; Jaana Tolvanen; Eevi Kaasinen; Yilong Li; Heli J Lehtonen; Massimiliano Gentile; Jian Yan; Martin Enge; Minna Taipale; Mervi Aavikko; Riku Katainen; Elina Virolainen; Tom Böhling; Taru A Koski; Virpi Launonen; Jari Sjöberg; Jussi Taipale; Pia Vahteristo; Lauri A Aaltonen
Journal:  Science       Date:  2011-08-25       Impact factor: 47.728

3.  Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers.

Authors:  Kathleen M Murphy; Shengle Zhang; Tanya Geiger; Michael J Hafez; Jeff Bacher; Karin D Berg; James R Eshleman
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 4.  Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets?

Authors:  Ashraf A Khalil; Nihal F Kabapy; Sahar F Deraz; Christopher Smith
Journal:  Biochim Biophys Acta       Date:  2011-05-14

5.  Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma.

Authors:  Ali Aghdassi; Phoebe Phillips; Vikas Dudeja; Dhara Dhaulakhandi; Rifat Sharif; Rajinder Dawra; Markus M Lerch; Ashok Saluja
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

6.  Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma.

Authors:  Weng Khong Lim; Choon Kiat Ong; Jing Tan; Aye Aye Thike; Cedric Chuan Young Ng; Vikneswari Rajasegaran; Swe Swe Myint; Sanjanaa Nagarajan; Nur Diyana Md Nasir; John R McPherson; Ioana Cutcutache; Gregory Poore; Su Ting Tay; Wei Siong Ooi; Veronique Kiak Mien Tan; Mikael Hartman; Kong Wee Ong; Benita K T Tan; Steven G Rozen; Puay Hoon Tan; Patrick Tan; Bin Tean Teh
Journal:  Nat Genet       Date:  2014-07-20       Impact factor: 38.330

7.  Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity.

Authors:  Mikko Turunen; Jason M Spaeth; Salla Keskitalo; Min Ju Park; Teemu Kivioja; Alison D Clark; Netta Mäkinen; Fangjian Gao; Kimmo Palin; Helka Nurkkala; Anna Vähärautio; Mervi Aavikko; Kati Kämpjärvi; Pia Vahteristo; Chongwoo A Kim; Lauri A Aaltonen; Markku Varjosalo; Jussi Taipale; Thomas G Boyer
Journal:  Cell Rep       Date:  2014-04-18       Impact factor: 9.423

Review 8.  Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.

Authors:  Kohzoh Imai; Hiroyuki Yamamoto
Journal:  Carcinogenesis       Date:  2007-10-17       Impact factor: 4.944

Review 9.  The Mediator complex and transcription regulation.

Authors:  Zachary C Poss; Christopher C Ebmeier; Dylan J Taatjes
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-03       Impact factor: 8.250

10.  Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas.

Authors:  N Mäkinen; H-R Heinonen; J Sjöberg; J Taipale; P Vahteristo; L A Aaltonen
Journal:  Br J Cancer       Date:  2014-03-18       Impact factor: 7.640

View more
  7 in total

1.  Intratumoral Heterogeneity of Frameshift Mutations of GLI1 Encoding a Hedgehog Signaling Protein in Colorectal Cancers.

Authors:  Ju Hwa Lee; Sang Yong Song; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2017-06-29       Impact factor: 3.201

2.  Intratumoral Heterogeneity of Somatic Mutations for NRIP1, DOK1, ULK1, ULK2, DLGAP3, PARD3 and PRKCI in Colon Cancers.

Authors:  Eun Ji Choi; Ju Hwa Lee; Min Sung Kim; Sang Yong Song; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2017-08-26       Impact factor: 3.201

3.  Inactivating Frameshift Mutations of HACD4 and TCP10L Tumor Suppressor Genes in Colorectal and Gastric Cancers.

Authors:  Yun Sol Jo; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2018-03-12       Impact factor: 3.201

4.  TRIO Gene Encoding Trio Rho Guanine Nucleotide Exchange Factor Harbors Frameshift Mutations of in Gastric and Colorectal Cancers.

Authors:  Eun Ji Choi; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2017-02-21       Impact factor: 3.201

5.  Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.

Authors:  Su Yeon Yeon; Yun Sol Jo; Eun Ji Choi; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2017-08-12       Impact factor: 3.201

6.  Frameshift Mutations and Loss of Expression of CLCA4 Gene are Frequent in Colorectal Cancers With Microsatellite Instability.

Authors:  Ha Yoon Mo; Ju Hwa Lee; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-08

7.  HSPA4 Knockdown Retarded Progression and Development of Colorectal Cancer.

Authors:  Mingliang Zhang; Weigang Dai; Zhanyu Li; Liang Tang; Jianhui Chen; Chuangqi Chen
Journal:  Cancer Manag Res       Date:  2021-06-14       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.